Integra LifeSciences Holdings Corporation (IART) short interest & options flow
NASDAQIntegra LifeSciences reports Q3 results on October 29 with the Street in near-unanimous retreat mode: every analyst action in the past two weeks has been a target cut, and the stock has shed 25% over the past month to close at $12.10. The analyst reset is the defining feature of this setup. Five firms trimmed targets in a single day on October 22, including JP Morgan cutting from…
IART retail attention surges 7.75 standard deviations above its own 90-day history, per Wikipedia views and ORTEX stock-page data as of September 27.
- Market cap
- $1.04B
- Next earnings
- 25 Feb 2027
Key data as of 7 Nov 2026

IART news and analysis
RSSNo long-form analysis yet for IART. Pulse alerts and the live data picture are available on ORTEX.
Open IART on ORTEX →Want the live picture for IART?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IART — free to start on ORTEX.
Sign up for free →Open IART on ORTEX